Akèy › Kansè Endomèt › Tennessee › Chattanooga
Etid klinik pou Kansè Endomèt nan Chattanooga, TN
3 etid pou Kansè Endomèt ap chèche patisipan nan sit nan ak bò kote Chattanooga (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Ap rekriteFaz 3
- Erlanger Medical Center ( Site 5009), Chattanooga
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Ap rekriteFaz 1/2
- Erlanger Health, Inc, Chattanooga
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Ap rekriteFaz 1/2
- Tennessee Oncology, PLLC, Chattanooga
Etid Kansè Endomèt nan lòt vil
- Houston, TX68 etid
- New York City, NY52 etid
- Boston, MA50 etid
- Arlington, VA39 etid
- Nashville, TN38 etid
- Los Angeles, CA34 etid
- St. Louis, MO29 etid
- Philadelphia, PA28 etid
- San Antonio, TX27 etid
- Columbus, OH25 etid
- Oklahoma City, OK25 etid
- Chicago, IL25 etid
Lòt etid nan Chattanooga
- Kansè Poumon ki pa ti selil11 etid
- Kansè Metastatik6 etid
- Miasteni grav6 etid
- Kansè ovè5 etid
- Dyabèt4 etid
- Maladi fwa steatotik4 etid
- Melanom4 etid
- Akidan serebral iskemi4 etid
- Kansè kolorektal4 etid
- Maladi ren kwonik4 etid
- Kansè poumon4 etid
- Ensifizans renn3 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.